Skip to content
MARKETS / BALCAO / XAGE
BALCAO · SOAP, DETERGENTS, CLEANG PREPARATIONS, PERFUMES, COSMETICS

Longevity Health Holdings, Inc. XAGE

5 fiscal years on record · USD · FY2025 reported · SEC filings only
$1.9M
▲ 3701.4% YoY
$-6.9M
$-3.3M
In brief

What this company does

We currently have two cosmetic product lines, Elevai ExosomesTM and Carmell SecretomeTM, that support skin and hair health. The skincare and haircare products acquired in conjunction with the Elevai Acquisition (as defined in Note 1 to the accompanying consolidated financial statements) in January 2025 utilize Elevai ExosomesTM, which are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Carmell SecretomeTM consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. We currently sell our cosmetics products in the United States through three distinct channels, including business-to-business, direct-to-consumer, and, in the case of Elevai products, distributor sales channels. As of March 27, 2026, we have ten full-time employees.

Written from the business description in Longevity Health Holdings, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 31 March 2026. Every sentence was checked against that document before publication.

Growth
USD 1.9M
Revenue, FY2025 · full 5-year series below
Revenue $M Net income $M
FY2025 · Revenue 1.9 · Net income -6.9
0.8M1.6M-8.0M20212022202320242025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−361 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -371.6% · Net -361.0%
-10000%-20000%20212022202320242025
ROE

Not applicable: equity was negative in this period, so return on equity has no meaning.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -3.3
-4M-8M20212022202320242025
Net buybacks $ Dividends $
FY2023 · Dividends — · Net buybacks -41073.0
-20000-4000020222023

Total assetsUSD 2.4M
EquityUSD -5.9M
CashUSD 706,740.00
Current ratio0.25×

Equity funds -248% of total assets.

The 5-year record
5 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021
Revenue $B0.00.00.0··
Operating income $B−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0·
Income tax $B0.0−0.00.00.00.0
Net income $B−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0·−0.0−0.0·
EPS, diluted $−4.83−14.56−1.46−5.47·
Dividend / sh $·····
Payout %·····
ROE %·−103.5···
Shares out B0.000.000.020.00·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 22 reconciliationsAUDITED

Reconciled in 5 of 19 fiscal years. 73 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivitySoap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Listed onOTC market
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2021

Share this section

Download image